Latest News

Blocking key enzyme minimizes stroke injury, research finds

A drug that blocks the action of the enzyme Cdk5 could substantially reduce brain damage if administered shortly after a stroke, research suggests. The development of a Cdk5 inhibitor as an acute neuroprotective therapy has the potential to reduce stroke injury, researchers report.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Largest-ever autism genome study finds most siblings have different autism-risk genes

  • Possible therapeutic target for common, but mysterious brain blood vessel disorder

  • Higher dementia risk linked to more use of common drugs

  • Girls lead boys in academic achievement globally

  • Students master math through movement using Kinect for Windows

  • Phase 1 clinical trial of CUDC-101 'throws kitchen sink' at head and neck cancer

  • Engineering self-assembling amyloid fibers

  • Majority of homeless adults with mental illness have high rates of cognitive deficits

  • Brain study sheds light on how children with autism process social play

  • Is head CT overused in emergency departments?

  •